Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome Journal Article


Authors: Labuhn, M.; Perkins, K.; Matzk, S.; Varghese, L.; Garnett, C.; Papaemmanuil, E.; Metzner, M.; Kennedy, A.; Amstislavskiy, V.; Risch, T.; Bhayadia, R.; Samulowski, D.; Hernandez, D. C.; Stoilova, B.; Iotchkova, V.; Oppermann, U.; Scheer, C.; Yoshida, K.; Schwarzer, A.; Taub, J.; Crispino, J. D.; Weiss, M. J.; Hayashi, Y.; Taga, T.; Ito, E.; Ogawa, S.; Reinhardt, D.; Yaspo, M. L.; Campbell, P. J.; Roberts, I.; Constantinescu, S.; Vyas, P.; Heckl, D.; Klusmann, J. H.
Article Title: Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome
Abstract: Myeloid leukemia in Down syndrome (ML-DS) clonally evolves from transient abnormal myelopoiesis (TAM), a preleukemic condition in DS newborns. To define mechanisms of leukemic transformation, we combined exome and targeted resequencing of 111 TAM and 141 ML-DS samples with functional analyses. TAM requires trisomy 21 and truncating mutations in GATA1; additional TAM variants are usually not pathogenic. By contrast, in ML-DS, clonal and subclonal variants are functionally required. We identified a recurrent and oncogenic hotspot gain-of-function mutation in myeloid cytokine receptor CSF2RB. By a multiplex CRISPR/Cas9 screen in an in vivo murine TAM model, we tested loss-of-function of 22 recurrently mutated ML-DS genes. Loss of 18 different genes produced leukemias that phenotypically, genetically, and transcriptionally mirrored ML-DS. Copyright © 2019 Elsevier Inc. All rights reserved.
Keywords: down syndrome; acute myeloid leukemia; preleukemia; gata1; cancer transformation; crispr screen
Journal Title: Cancer Cell
Volume: 36
Issue: 2
ISSN: 1535-6108
Publisher: Cell Press  
Date Published: 2019-08-12
Start Page: 123
End Page: 138.e10
Language: English
DOI: 10.1016/j.ccell.2019.06.007
PUBMED: 31303423
PROVIDER: scopus
PMCID: PMC6863161
DOI/URL:
Notes: Article -- Erratum issued, see DOI: 10.1016/j.ccell.2019.08.014 --Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors